Prenatal tobacco prevention and cessation interventions for women in low‐ and middle‐income countries
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Although the prevalence of tobacco use is decreasing in many high‐income countries, it is increasing in many low‐ and middle‐income countries. The health and economic burden of increasing tobacco use and dependence is predictable and will have devastating effects in countries with limited resources, particularly for vulnerable populations such as pregnant women. We sought to review effective tobacco prevention and intervention strategies for decreasing tobacco use and secondhand smoke exposure before and during pregnancy in high‐, middle‐, and low‐income countries. We reviewed several types of interventions, including population‐level efforts (increasing tobacco prices, implementing tobacco control policies), community interventions, clinical interventions, and pharmacological treatments. A second purpose of this report is to present findings of an international expert working group that was convened to review the evidence and to establish research priorities in the following areas: (a) preventing the uptake and reducing tobacco use among girls and women of reproductive age; and (b) reducing tobacco use and secondhand smoke exposure among pregnant women. The working group considered the evidence on existing interventions in terms of burden of disease, intervention impact, intervention costs, feasibility of integration into existing services, uniqueness of the contribution, and overall feasibility. Finally, we present the working group's recommendations for intervention research priorities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930
Interventions for promoting smoking cessation during pregnancy
Lumley, J., Chamberlain, C., Dowswell, T., Oliver, S., Oakley, L., & Watson, L. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001055.pub3 · Cited by 890
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., & Lancaster, T. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub3 · Cited by 721
Antidepressants for smoking cessation
Hughes, J. R., Stead, L. F., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub3 · Cited by 567
Hopkins, D. P., Briss, P. A., Ricard, C. J., Husten, C. G., Carande-Kulis, V. G., Fielding, J. E., Alao, M. O., McKenna, J. W., Sharp, D. J., Harris, J. R., et al. (2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(00)00297-x · Cited by 453
Risks and Benefits of Nicotine to Aid Smoking Cessation in Pregnancy
Dempsey, D. A., & Benowitz, N. L. (2001) · Drug Safety · doi:10.2165/00002018-200124040-00005 · Cited by 346 · cited 1×
“Although the risks of nicotine in human pregnancy are not fully known, based on the adverse effects of nicotine in animal studies, it seems prudent to minimize the amount of nicotine exposure with NRT if used during pregnancy (53).”
BackgroundGraphic Canadian cigarette warning labels and adverse outcomes: evidence from Canadian smokers
Hammond, D., Fong, G. T., McDonald, P. W., Brown, K. S., & Cameron, R. (2004) · American Journal of Public Health · doi:10.2105/ajph.94.8.1442 · Cited by 331 · cited 1×
“Large graphic (pictorial) warning labels, which are especially effective, were first introduced by Canada in 2000, and have now been implemented in more than 20 countries (43,44).”
BackgroundSlotkin, T. A. (2008) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2007.09.002 · Cited by 206
Bupropion in pregnancy and the prevalence of congenital malformations
Cole, J. A., Modell, J. G., Haight, B. R., Cosmatos, I. S., Stoler, J. M., & Walker, A. M. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1296 · Cited by 149 · cited 2×
“Large placebo-controlled studies examining the potential safety, tolerability, or efficacy of bupropion SR or varenicline for smoking cessation during pregnancy have not been conducted (54,55,59).”
Background
Cited by
Pharmacological interventions for promoting smoking cessation during pregnancy
Coleman, T., Chamberlain, C., Davey, M.-A., Cooper, S. E., & Leonardi-Bee, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010078.pub2 · Cited by 357
Pharmacological interventions for promoting smoking cessation during pregnancy
Claire, R., Chamberlain, C., Davey, M.-A., Cooper, S. E., Berlin, I., Leonardi-Bee, J., & Coleman, T. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010078.pub3 · Cited by 188
Cooper, S., Lewis, S., Thornton, J. G., Marlow, N., Watts, K., Britton, J., Grainge, M. J., Taggar, J., Essex, H., Parrott, S., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18540 · Cited by 103
Cooper, S., Taggar, J., Lewis, S., Marlow, N., Dickinson, A., Whitemore, R., & Coleman, T. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70157-2 · Cited by 73
Essex, H. N., Parrott, S., Wu, Q., Li, J., Cooper, S., & Coleman, T. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntu258 · Cited by 9
Metadata
- Authors
- ONCKEN, C. A., DIETZ, P. M., TONG, V. T., BELIZÁN, J. M., TOLOSA, J. E., BERGHELLA, V., GOLDENBERG, R. L., LANDO, H. A., SAMET, J. M., & BLOCH, M. H.
- Venue
- Acta Obstetricia et Gynecologica Scandinavica
- Publisher
- Wiley
- Published
- 2010-04
- Volume
- 89
- Issue
- 4
- Pages
- 442-453
- ISSN
- 0001-6349 (ISSN-L)
- 1600-0412
- OpenAlex
- W2041347461
- Cited by
- 49
- References
- 14
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prenatal tobacco prevention and cessation interventions for women in low‐ and middle‐income countries. https://app.cochat.ai/papers/10.3109/00016341003678450
- The paper
- ONCKEN, C. A., DIETZ, P. M., TONG, V. T., BELIZÁN, J. M., TOLOSA, J. E., BERGHELLA, V., GOLDENBERG, R. L., LANDO, H. A., SAMET, J. M., & BLOCH, M. H. (2010). Prenatal tobacco prevention and cessation interventions for women in low‐ and middle‐income countries. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.3109/00016341003678450
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.